| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.001 | 0.984 | Gastric antisecretory | 0.973 0.001 DBMET01494 0.939 0.001 DBMET03753 0.984 0.001 DBMET03755 0.837 0.002 DBMET03751 0.926 0.001 DBMET03754 0.944 0.001 DBMET03757 0.713 0.002 DBMET03756 | DBMET03755 | |
| 0.976 | 0.001 | 0.976 | Potassium channel (ATP-sensitive) blocker | 0.968 0.001 DBMET01494 0.493 0.002 DBMET03753 0.381 0.002 DBMET03755 0.233 0.003 DBMET03751 0.462 0.002 DBMET03754 0.116 0.01 DBMET03757 0.066 0.047 DBMET03756 | ||
| 0.925 | 0.001 | 0.925 | H+/K+-transporting ATPase inhibitor | 0.854 0.001 DBMET01494 0.741 0.001 DBMET03753 0.823 0.001 DBMET03755 0.748 0.001 DBMET03751 0.721 0.001 DBMET03754 0.668 0.002 DBMET03757 0.475 0.003 DBMET03756 | ||
| 0.899 | 0.001 | 0.899 | Antibacterial (Helicobacter pylori) | 0.897 0.001 DBMET01494 0.579 0.003 DBMET03753 0.795 0.002 DBMET03755 0.793 0.002 DBMET03751 0.576 0.003 DBMET03754 0.774 0.002 DBMET03757 0.721 0.002 DBMET03756 | ||
| 0.686 | 0.005 | 0.686 | Potassium channel blocker | 0.613 0.005 DBMET01494 0.342 0.034 DBMET03755 0.211 0.085 DBMET03751 | ||
| 0.536 | 0.003 | 0.536 | ABCA1 expression enhancer | 0.51 0.003 DBMET01494 0.34 0.005 DBMET03753 0.439 0.004 DBMET03755 0.342 0.005 DBMET03751 0.298 0.005 DBMET03754 0.188 0.011 DBMET03757 0.155 0.016 DBMET03756 | ||
| 0.512 | 0.002 | 0.512 | Potassium channel (Inward rectifier) blocker | 0.447 0.002 DBMET01494 0.202 0.004 DBMET03753 0.132 0.005 DBMET03755 0.059 0.024 DBMET03751 0.127 0.005 DBMET03754 | ||
| 0.464 | 0.003 | 0.683 | ATPase inhibitor | 0.482 0.003 DBMET01494 0.198 0.039 DBMET03753 0.178 0.06 DBMET03755 0.683 0.002 DBMET03751 0.207 0.031 DBMET03754 0.497 0.003 DBMET03756 | DBMET03751 | |
| 0.436 | 0.004 | 0.436 | Gastrin inhibitor | 0.38 0.006 DBMET01494 0.274 0.054 DBMET03753 0.288 0.041 DBMET03755 0.351 0.01 DBMET03751 0.226 0.111 DBMET03754 0.257 0.071 DBMET03756 | ||
| 0.402 | 0.005 | 0.402 | Ca(v)3.3 blocker | 0.362 0.011 DBMET01494 0.402 0.005 DBMET03753 0.335 0.02 DBMET03755 0.269 0.074 DBMET03751 0.362 0.011 DBMET03754 0.347 0.015 DBMET03757 0.288 0.054 DBMET03756 | ||
| 0.385 | 0.007 | 0.385 | Interleukin 1 antagonist | 0.335 0.009 DBMET01494 0.239 0.021 DBMET03753 0.151 0.057 DBMET03755 0.246 0.019 DBMET03751 0.219 0.026 DBMET03754 0.145 0.061 DBMET03757 0.241 0.02 DBMET03756 | ||
| 0.432 | 0.059 | 0.548 | Histamine release inhibitor | 0.459 0.045 DBMET01494 0.378 0.087 DBMET03755 0.548 0.016 DBMET03751 0.274 0.139 DBMET03756 | DBMET03751 | |
| 0.361 | 0.043 | 0.361 | Calcium channel activator | 0.351 0.049 DBMET01494 0.293 0.099 DBMET03753 0.283 0.11 DBMET03754 | ||
| 0.288 | 0.009 | 0.288 | Interleukin 1b antagonist | 0.241 0.013 DBMET01494 0.182 0.024 DBMET03753 0.121 0.061 DBMET03755 0.196 0.02 DBMET03751 0.162 0.033 DBMET03754 0.112 0.068 DBMET03757 0.192 0.021 DBMET03756 | ||
| 0.264 | 0.004 | 0.264 | Histamine H2 receptor antagonist | 0.169 0.007 DBMET01494 0.081 0.063 DBMET03753 | ||
| 0.217 | 0.076 | 0.259 | Interleukin antagonist | 0.259 0.058 DBMET01494 0.143 0.123 DBMET03753 0.167 0.106 DBMET03751 0.197 0.086 DBMET03754 0.176 0.099 DBMET03756 | DBMET01494 | |
| 0.169 | 0.028 | 0.169 | MAP kinase 13 inhibitor | 0.133 0.045 DBMET01494 0.095 0.09 DBMET03753 | ||
| 0.172 | 0.032 | 0.172 | MAP kinase 12 inhibitor | 0.141 0.048 DBMET01494 0.105 0.091 DBMET03753 | ||
| 0.286 | 0.146 | 0.668 | Antibacterial | 0.334 0.111 DBMET01494 0.451 0.057 DBMET03755 0.661 0.012 DBMET03751 0.242 0.184 DBMET03754 0.455 0.055 DBMET03757 0.668 0.011 DBMET03756 | DBMET03756 | |
| 0.141 | 0.005 | 0.168 | Fatty acid synthase inhibitor | 0.168 0.004 DBMET01494 0.084 0.017 DBMET03751 | DBMET01494 | |
| 0.137 | 0.045 | 0.137 | Alpha 2b adrenoreceptor antagonist | 0.12 0.058 DBMET01494 | ||
| 0.112 | 0.022 | 0.137 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 DBMET01494 0.117 0.018 DBMET03755 0.137 0.009 DBMET03751 0.07 0.06 DBMET03757 0.11 0.023 DBMET03756 | DBMET03751 | |
| 0.134 | 0.051 | 0.136 | Sphingosine 1-phosphate receptor 4 antagonist | 0.114 0.085 DBMET01494 0.136 0.048 DBMET03753 0.116 0.081 DBMET03754 | DBMET03753 | |
| 0.143 | 0.065 | 0.168 | Bone formation stimulant | 0.168 0.047 DBMET01494 0.148 0.06 DBMET03751 | DBMET01494 | |
| 0.1 | 0.023 | 0.115 | Ca(v)3.1 blocker | 0.092 0.033 DBMET01494 0.115 0.013 DBMET03753 0.105 0.019 DBMET03754 | DBMET03753 | |
| 0.106 | 0.042 | 0.152 | Phosphodiesterase 6D inhibitor | 0.107 0.041 DBMET01494 0.152 0.009 DBMET03751 0.099 0.054 DBMET03756 | DBMET03751 | |
| 0.07 | 0.01 | 0.07 | Histamine H2 receptor agonist | |||
| 0.186 | 0.132 | 0.291 | Spasmolytic | 0.198 0.121 DBMET01494 0.291 0.073 DBMET03751 | DBMET03751 | |
| 0.154 | 0.111 | 0.162 | P-glycoprotein inhibitor | 0.153 0.113 DBMET01494 0.162 0.099 DBMET03751 | DBMET03751 | |
| 0.082 | 0.046 | 0.082 | Viral attachment inhibitor | |||
| 0.065 | 0.03 | 0.077 | Ca(v)3.2 blocker | 0.058 0.044 DBMET01494 0.077 0.017 DBMET03753 0.068 0.025 DBMET03754 | DBMET03753 | |
| 0.076 | 0.051 | 0.076 | MAP kinase 11 inhibitor | |||
| 0.103 | 0.079 | 0.103 | Calcium channel (voltage-sensitive) blocker | |||
| 0.056 | 0.042 | 0.067 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.049 DBMET01494 0.059 0.034 DBMET03753 0.056 0.041 DBMET03754 0.064 0.025 DBMET03757 0.067 0.02 DBMET03756 | DBMET03756 | |
| 0.107 | 0.116 | 0.269 | Cyclooxygenase inhibitor | 0.269 0.023 DBMET03753 0.25 0.026 DBMET03754 | DBMET03753 | |
| 0.15 | 0.18 | 0.526 | Hypoglycemic | 0.192 0.12 DBMET01494 0.517 0.014 DBMET03751 0.526 0.013 DBMET03756 | DBMET03756 | |
| 0.117 | 0.156 | 0.19 | Interleukin 6 antagonist | 0.134 0.118 DBMET01494 0.19 0.047 DBMET03751 | DBMET03751 | |
| 0.164 | 0.218 | 0.427 | Angiogenesis inhibitor | 0.194 0.177 DBMET01494 0.29 0.098 DBMET03755 0.278 0.104 DBMET03751 0.195 0.175 DBMET03754 0.427 0.046 DBMET03757 0.399 0.054 DBMET03756 | DBMET03757 | |
| 0.065 | 0.13 | 0.112 | Thioredoxin inhibitor | 0.104 0.044 DBMET03751 0.086 0.068 DBMET03754 0.112 0.037 DBMET03756 | DBMET03756 | |
| 0.065 | 0.164 | 0.252 | Cyclooxygenase 1 inhibitor | 0.252 0.021 DBMET03753 0.248 0.022 DBMET03754 0.119 0.081 DBMET03757 0.105 0.095 DBMET03756 | DBMET03753 | |
| 0.06 | 0.177 | 0.234 | Cyclooxygenase 2 inhibitor | 0.234 0.023 DBMET03753 0.21 0.028 DBMET03754 | DBMET03753 | |
| 0.014 | 0.238 | 0.03 | Purinergic P2Y2 antagonist | 0.03 0.029 DBMET03757 | DBMET03757 | |
| 0.064 | 0.302 | 0.276 | Hypolipemic | 0.194 0.099 DBMET03751 0.276 0.057 DBMET03756 | DBMET03756 | |
| 0.108 | 0.376 | 0.317 | Peptidyltransferase inhibitor | 0.317 0.019 DBMET03751 0.29 0.028 DBMET03756 | DBMET03751 | |
| 0.013 | 0.293 | 0.064 | Elastase inhibitor | 0.052 0.039 DBMET03755 0.064 0.027 DBMET03757 | DBMET03757 | |
| 0.019 | 0.324 | 0.07 | Carbonic anhydrase XIII inhibitor | 0.07 0.058 DBMET03757 | DBMET03757 | |
| 0.013 | 0.331 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET03757 0.025 0.021 DBMET03756 | DBMET03756 | |
| 0.055 | 0.381 | 0.171 | Insulin secretagoues | 0.165 0.06 DBMET03751 0.171 0.055 DBMET03756 | DBMET03756 | |
| 0.022 | 0.359 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.062 DBMET03756 | DBMET03756 | |
| 0.022 | 0.359 | 0.065 | Histone deacetylase stimulant | 0.065 0.062 DBMET03756 | DBMET03756 | |
| 0.033 | 0.375 | 0.224 | Amylase inhibitor | 0.167 0.056 DBMET03751 0.224 0.036 DBMET03756 | DBMET03756 | |
| 0.004 | 0.352 | 0.183 | Cholecystokinin A agonist | 0.176 0.003 DBMET03755 0.183 0.003 DBMET03757 | DBMET03757 | |
| 0.077 | 0.432 | 0.259 | Transcription factor inhibitor | 0.259 0.181 DBMET03753 | DBMET03753 | |
| 0.051 | 0.409 | 0.147 | Non-steroidal antiinflammatory agent | 0.137 0.136 DBMET03751 0.147 0.119 DBMET03756 | DBMET03756 | |
| 0.048 | 0.413 | 0.195 | Vasodilator | 0.195 0.109 DBMET03751 | DBMET03751 | |
| 0.042 | 0.407 | 0.183 | Platelet antagonist | 0.183 0.115 DBMET03751 | DBMET03751 | |
| 0.006 | 0.372 | 0.043 | Leukocyte elastase inhibitor | 0.043 0.03 DBMET03757 | DBMET03757 | |
| 0.004 | 0.387 | 0.213 | Cholecystokinin agonist | 0.203 0.003 DBMET03755 0.213 0.003 DBMET03757 | DBMET03757 | |
| 0.025 | 0.408 | 0.182 | AMP-activated protein kinase stimulant | 0.123 0.046 DBMET03751 0.182 0.014 DBMET03756 | DBMET03756 | |
| 0.005 | 0.389 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 DBMET03756 | DBMET03756 | |
| 0.12 | 0.511 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET01494 0.235 0.222 DBMET03754 | DBMET03754 | |
| 0.084 | 0.484 | 0.129 | CC chemokine 6 receptor antagonist | 0.127 0.081 DBMET03751 0.129 0.076 DBMET03756 | DBMET03756 | |
| 0.06 | 0.481 | 0.33 | Cholesterol antagonist | 0.183 0.181 DBMET03757 0.33 0.074 DBMET03756 | DBMET03756 | |
| 0.04 | 0.477 | 0.109 | Interleukin 12 antagonist | 0.109 0.041 DBMET03754 0.092 0.068 DBMET03756 | DBMET03754 | |
| 0.039 | 0.476 | 0.405 | Thioredoxin glutathione reductase inhibitor | 0.405 0.055 DBMET03753 0.366 0.07 DBMET03754 | DBMET03753 | |
| 0.003 | 0.451 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.022 DBMET03756 | DBMET03756 | |
| 0.006 | 0.467 | 0.119 | NMDA 2B receptor antagonist | 0.095 0.017 DBMET03755 0.119 0.012 DBMET03757 | DBMET03757 | |
| 0.044 | 0.511 | 0.174 | NOS3 expression enhancer | 0.15 0.072 DBMET03751 0.174 0.054 DBMET03756 | DBMET03756 | |
| 0.025 | 0.493 | 0.433 | Angiogenesis stimulant | 0.255 0.067 DBMET03755 0.414 0.02 DBMET03751 0.315 0.044 DBMET03757 0.433 0.017 DBMET03756 | DBMET03756 | |
| 0.013 | 0.499 | 0.056 | Heparanase inhibitor | 0.051 0.044 DBMET03751 0.056 0.03 DBMET03756 | DBMET03756 | |
| 0.019 | 0.523 | 0.109 | Beta glucuronidase inhibitor | 0.109 0.058 DBMET03756 | DBMET03756 | |
| 0.029 | 0.534 | 0.188 | Streptokinase A inhibitor | 0.188 0.14 DBMET03754 | DBMET03754 | |
| 0.016 | 0.531 | 0.05 | Factor IXa inhibitor | 0.05 0.037 DBMET03756 | DBMET03756 | |
| 0.012 | 0.571 | 0.122 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 DBMET03755 | DBMET03755 | |
| 0.029 | 0.599 | 0.089 | Transcription factor NF kappa B stimulant | 0.084 0.061 DBMET03751 0.089 0.052 DBMET03756 | DBMET03756 | |
| 0.016 | 0.587 | 0.204 | Dual specificity phosphatase 3 inhibitor | 0.163 0.085 DBMET03755 0.204 0.059 DBMET03757 | DBMET03757 | |
| 0.034 | 0.611 | 0.229 | Antiobesity | 0.229 0.177 DBMET03757 | DBMET03757 | |
| 0.009 | 0.596 | 0.367 | Cholecystokinin B agonist | 0.345 0.003 DBMET03755 0.367 0.003 DBMET03757 | DBMET03757 | |
| 0.049 | 0.642 | 0.62 | Cyclophilin D inhibitor | 0.548 0.038 DBMET03751 0.276 0.185 DBMET03757 0.62 0.024 DBMET03756 | DBMET03756 | |
| 0.004 | 0.608 | 0.075 | Antineoplastic antibiotic | 0.072 0.063 DBMET03751 0.075 0.061 DBMET03756 | DBMET03756 | |
| 0.032 | 0.65 | 0.261 | Hepatoprotectant | 0.252 0.043 DBMET03751 0.261 0.04 DBMET03756 | DBMET03756 | |
| 0.018 | 0.651 | 0.17 | Cell wall synthesis inhibitor | 0.17 0.047 DBMET03756 | DBMET03756 | |
| 0.014 | 0.65 | 0.367 | Alpha-glucosidase inhibitor | 0.367 0.128 DBMET03756 | DBMET03756 | |
| 0.018 | 0.669 | 0.134 | Hemostatic | 0.134 0.089 DBMET03756 | DBMET03756 | |
| 0.014 | 0.681 | 0.175 | Dual specificity phosphatase inhibitor | 0.14 0.106 DBMET03755 0.175 0.071 DBMET03757 | DBMET03757 | |
| 0.009 | 0.679 | 0.131 | Lipid peroxidase inhibitor | 0.126 0.088 DBMET03751 0.131 0.083 DBMET03756 | DBMET03756 | |
| 0.014 | 0.688 | 0.348 | Antioxidant | 0.326 0.053 DBMET03751 0.348 0.047 DBMET03756 | DBMET03756 | |
| 0.01 | 0.702 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.039 DBMET03756 | DBMET03756 | |
| 0.01 | 0.733 | 0.085 | ATPase (Vacuolar H+) inhibitor | 0.085 0.066 DBMET03756 | DBMET03756 | |
| 0.035 | 0.763 | 0.289 | Apoptosis antagonist | 0.259 0.119 DBMET03751 0.289 0.093 DBMET03756 | DBMET03756 | |
| 0.019 | 0.757 | 0.283 | Immunosuppressant | 0.283 0.126 DBMET03751 0.252 0.146 DBMET03756 | DBMET03751 | |
| 0.01 | 0.794 | 0.188 | Nitric oxide antagonist | 0.183 0.075 DBMET03751 0.188 0.072 DBMET03756 | DBMET03756 | |
| 0.003 | 0.791 | 0.07 | Cholecystokinin A antagonist | 0.063 0.016 DBMET03755 0.07 0.014 DBMET03757 | DBMET03757 | |
| 0.007 | 0.809 | 0.293 | Free radical scavenger | 0.263 0.063 DBMET03751 0.293 0.054 DBMET03756 | DBMET03756 | |
| 0.006 | 0.812 | 0.057 | Protein 50S ribosomal subunit inhibitor | 0.057 0.033 DBMET03751 0.055 0.035 DBMET03756 | DBMET03751 | |
| 0.019 | 0.829 | 0.487 | Antiinflammatory | 0.431 0.121 DBMET03751 0.487 0.093 DBMET03756 | DBMET03756 | |
| 0.003 | 0.813 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 DBMET03755 0.037 0.031 DBMET03757 | DBMET03755 | |
| 0.003 | 0.876 | 0.196 | Selectin antagonist | 0.184 0.013 DBMET03751 0.196 0.012 DBMET03756 | DBMET03756 | |
| 0.037 | 0.92 | 0.282 | Interleukin 2 agonist | 0.271 0.097 DBMET03751 0.282 0.087 DBMET03756 | DBMET03756 | |
| 0.005 | 0.92 | 0.049 | Antibiotic Aminoglycoside-like | 0.047 0.015 DBMET03751 0.049 0.014 DBMET03756 | DBMET03756 | |
| 0.005 | 0.923 | 0.159 | Anticoagulant | 0.144 0.086 DBMET03755 0.159 0.073 DBMET03757 | DBMET03757 | |
| 0.005 | 0.946 | 0.118 | Thrombolytic | 0.118 0.113 DBMET03756 | DBMET03756 | |
| 0.005 | 0.949 | 0.299 | Apoptosis agonist | 0.299 0.173 DBMET03756 | DBMET03756 | |
| 0.006 | 0.962 | 0.15 | Platelet adhesion inhibitor | 0.143 0.114 DBMET03757 0.15 0.106 DBMET03756 | DBMET03756 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |